| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |